ANTI D (RHOPHYLAC) INJ

Anti D (Rhophylac) injection is an immunoglobulin preparation used to prevent Rh sensitization in Rh-negative individuals. Administered following delivery, miscarriage, or potentially sensitizing events during pregnancy, this injection neutralizes fetal red blood cells that may enter maternal circulation. By preventing maternal antibody formation against Rh-positive blood, it reduces the risk of hemolytic disease in future pregnancies. Rhophylac offers rapid onset of action and is suitable for both intramuscular and intravenous administration, providing reliable protection when administered within the critical window following sensitizing events.